» Articles » PMID: 24205470

GMP-level Adipose Stem Cells Combined with Computer-aided Manufacturing to Reconstruct Mandibular Ameloblastoma Resection Defects: Experience with Three Cases

Overview
Date 2013 Nov 9
PMID 24205470
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The current management of large mandibular resection defects involves harvesting of autogenous bone grafts and repeated bending of generic reconstruction plates. However, the major disadvantage of harvesting large autogenous bone grafts is donor site morbidity and the major drawback of repeated reconstruction plate bending is plate fracture and difficulty in reproducing complex facial contours. The aim of this study was to describe reconstruction of three mandibular ameloblastoma resection defects using tissue engineered constructs of beta-tricalcium phosphate (β-TCP) granules, recombinant human bone morphogenetic protein-2 (rhBMP-2), and Good Manufacturing Practice (GMP) level autologous adipose stem cells (ASCs) with progressively increasing usage of computer-aided manufacturing (CAM) technology.

Materials And Methods: Patients' three-dimensional (3D) images were used in three consecutive patients to plan and reverse-engineer patient-specific saw guides and reconstruction plates using computer-aided additive manufacturing. Adipose tissue was harvested from the anterior abdominal walls of three patients before resection. ASCs were expanded ex vivo over 3 weeks and seeded onto a β-TCP scaffold with rhBMP-2. Constructs were implanted into patient resection defects together with rapid prototyped reconstruction plates.

Results: All three cases used one step in situ bone formation without the need for an ectopic bone formation step or vascularized flaps. In two of the three patients, dental implants were placed 10 and 14 months following reconstruction, allowing harvesting of bone cores from the regenerated mandibular defects. Histological examination and in vitro analysis of cell viability and cell surface markers were performed and prosthodontic rehabilitation was completed.

Discussion: Constructs with ASCs, β-TCP scaffolds, and rhBMP-2 can be used to reconstruct a variety of large mandibular defects, together with rapid prototyped reconstruction hardware which supports placement of dental implants.

Citing Articles

Stem Cells in Bone Tissue Engineering: Progress, Promises and Challenges.

Augustine R, Gezek M, Nikolopoulos V, Buck P, Bostanci N, Camci-Unal G Stem Cell Rev Rep. 2024; 20(7):1692-1731.

PMID: 39028416 DOI: 10.1007/s12015-024-10738-y.


Tissue Engineering and Regenerative Medicine in the Field of Otorhinolaryngology.

Oh S, Kim H, Jung S, Kim H Tissue Eng Regen Med. 2024; 21(7):969-984.

PMID: 39017827 PMC: 11416456. DOI: 10.1007/s13770-024-00661-1.


Reconstruction of Maxillary Defects Using Virtual Surgical Planning and Additive Manufacturing Technology: A Tertiary Care Centre Experience.

Kudva A, Srikanth G, Singh A, Chitra A, Suryanarayan R, Francis M J Maxillofac Oral Surg. 2024; 23(3):644-652.

PMID: 38911428 PMC: 11190103. DOI: 10.1007/s12663-023-02005-3.


Implant-supported prosthetic rehabilitation after Ameloblastomas treatment: a systematic review.

Alarcon-Sanchez M, Becerra-Ruiz J, Yessayan L, Mosaddad S, Heboyan A BMC Oral Health. 2023; 23(1):1013.

PMID: 38110933 PMC: 10729555. DOI: 10.1186/s12903-023-03765-7.


Biomaterials combined with ADSCs for bone tissue engineering: current advances and applications.

Song Y, Wang N, Shi H, Zhang D, Wang Q, Guo S Regen Biomater. 2023; 10:rbad083.

PMID: 37808955 PMC: 10551240. DOI: 10.1093/rb/rbad083.


References
1.
Behnia H, Khojasteh A, Soleimani M, Tehranchi A, Atashi A . Repair of alveolar cleft defect with mesenchymal stem cells and platelet derived growth factors: a preliminary report. J Craniomaxillofac Surg. 2011; 40(1):2-7. DOI: 10.1016/j.jcms.2011.02.003. View

2.
Haimi S, Moimas L, Pirhonen E, Lindroos B, Huhtala H, Raty S . Calcium phosphate surface treatment of bioactive glass causes a delay in early osteogenic differentiation of adipose stem cells. J Biomed Mater Res A. 2008; 91(2):540-7. DOI: 10.1002/jbm.a.32233. View

3.
Sieg P, Taner C, Hakim S, Jacobsen H . Long-term evaluation of donor site morbidity after free fibula transfer. Br J Oral Maxillofac Surg. 2009; 48(4):267-70. DOI: 10.1016/j.bjoms.2009.07.019. View

4.
Chamberlain G, Fox J, Ashton B, Middleton J . Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing. Stem Cells. 2007; 25(11):2739-49. DOI: 10.1634/stemcells.2007-0197. View

5.
Dragoo J, Lieberman J, Lee R, Deugarte D, Lee Y, ZuK P . Tissue-engineered bone from BMP-2-transduced stem cells derived from human fat. Plast Reconstr Surg. 2005; 115(6):1665-73. DOI: 10.1097/01.prs.0000161459.90856.ab. View